Safety Of Yellow Fever Vaccine And Other Live Attenuated Vaccines In Pediatric Patients With DiGeorge Syndrome

被引：0
|
作者：
de Souza, Mayara Lorena [1 ]
Dorna, Mayra de Barros [1 ]
Toscano Henriques, Gabriela Araujo [1 ]
Meireles Vieira, Pedro Henrique [1 ]
Grassi, Marcilia Sierro [1 ]
Beltran Moschione Castro, Ana Paula [1 ]
Pastorino, Antonio Carlos [1 ]
Carneiro-Sampaio, Magda [1 ]
机构：
[1] Univ Sao Paulo, Fac Med, Dept Pediat, Sao Paulo, Brazil
来源：
JOURNAL OF CLINICAL IMMUNOLOGY | 2020年 / 40卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
812236
引用
收藏
页码：S102 / S103
页数：2
相关论文
共 50 条
  • [31] Autoantibodies against type I IFNs in Patients With Life-Threatening Disease Due To Yellow Fever Live Attenuated Vaccine
    Bastard, Paul
    JOURNAL OF CLINICAL IMMUNOLOGY, 2021, 41 (SUPPL 1) : S8 - S8
  • [32] A SYSTEMATIC REVIEW OF THE SAFETY OF LICENSED LIVE ATTENUATED VACCINES
    Thomas, Nicole
    Epstein, Judith E.
    Hoffman, Stephen L.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2010, 83 (05): : 278 - 278
  • [33] Safety concerns with regard to live attenuated flavivirus vaccines
    Seligman, Stephen J.
    Gould, Ernest A.
    JOURNAL OF INFECTIOUS DISEASES, 2008, 198 (05): : 794 - 795
  • [34] Effectiveness and safety of immunization with live-attenuated and inactivated vaccines for pediatric liver transplantation recipients
    Kawano, Yoshihiko
    Suzuki, Michio
    Kawada, Jun-ichi
    Kimura, Hiroshi
    Kamei, Hideya
    Ohnishi, Yasuharu
    Ono, Yasuyuki
    Uchida, Hiroo
    Ogura, Yasuhiro
    Ito, Yoshinori
    VACCINE, 2015, 33 (12) : 1440 - 1445
  • [35] A Novel Live-Attenuated Vaccine Candidate for Mayaro Fever
    Weise, William J.
    Hermance, Meghan E.
    Forrester, Naomi
    Adams, A. Paige
    Langsjoen, Rose
    Gorchakov, Rodion
    Wang, Eryu
    Alcorn, Maria D. H.
    Tsetsarkin, Konstantin
    Weaver, Scott C.
    PLOS NEGLECTED TROPICAL DISEASES, 2014, 8 (08):
  • [36] Dendritic cells, macophages, and fibroblasts are the initial targets for replication of the live-attenuated yellow fever vaccine in the dermis
    Schmid, M. A.
    Mishra, N.
    Neyts, J.
    Dallmeier, K.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2017, 22 : 10 - 10
  • [37] Immunogenicity and Protective Efficacy of Aerosolized Live-Attenuated Yellow Fever 17D Vaccine in Mice
    Zhu, Feng
    Sun, Meng-Xu
    Zhao, Suo-Qun
    Qin, Cheng-Feng
    Wang, Jin-Hua
    Deng, Yong-Qiang
    VACCINES, 2024, 12 (08)
  • [38] A safer cell-based yellow fever live attenuated vaccine protects mice against YFV infection
    Guo, Weiwei
    Jiang, Tingting
    Rao, Juhong
    Zhang, Zihan
    Zhang, Xuekai
    Su, Jiaoling
    Yin, Chunhong
    Lu, Mingqing
    Hu, Xue
    Shan, Chao
    ISCIENCE, 2024, 27 (10)
  • [39] Understanding the role of innate immunity in the mechanism of action of the live attenuated yellow fever vaccine 17D
    Querec, Troy D.
    Pulendran, Bali
    CROSSROADS BETWEEN INNATE AND ADAPTIVE IMMUNITY, 2007, 590 : 43 - 53
  • [40] Safety of the Yellow Fever Vaccine: A Retrospective Study
    Nordin, James D.
    Parker, Emily D.
    Vazquez-Benitez, Gabriela
    Kharbanda, Elyse O.
    Naleway, Allison
    Marcy, S. Michael
    Molitor, Beth
    Kuckler, Leslie
    Baggs, James
    JOURNAL OF TRAVEL MEDICINE, 2013, 20 (06) : 368 - 373
12345